Olema Pharmaceuticals, Inc.
OLMA
$13.59
-$0.23-1.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -185.15M | -162.45M | -149.96M | -142.30M | -128.89M |
| Total Depreciation and Amortization | 481.00K | 490.00K | 419.00K | 471.00K | 433.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.08M | 12.47M | 14.05M | 14.74M | 15.29M |
| Change in Net Operating Assets | 16.86M | 2.78M | 814.00K | -73.00K | -11.66M |
| Cash from Operations | -148.72M | -146.72M | -134.67M | -127.16M | -124.83M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -106.15M | -155.76M | -108.00M | -79.35M | -118.46M |
| Cash from Investing | -106.15M | -155.76M | -108.00M | -79.35M | -118.47M |
| Total Debt Issued | 3.00M | 3.00M | 3.00M | 3.00M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 278.06M | 227.92M | 252.06M | 252.11M | 266.73M |
| Repurchase of Common Stock | -4.41M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -19.87M | -19.62M | -13.01M | -13.01M | -6.51M |
| Cash from Financing | 256.78M | 211.30M | 242.05M | 242.10M | 260.22M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.91M | -91.18M | -628.00K | 35.58M | 16.92M |